Behavioral
Ut Medical Group INC
Ut Medical Group INC was paid $53.16M by Medicaid between Jan 2018 and Dec 2024, across 228 billing codes. Its largest line is 99472, Subsequent inpatient pediatric critical care, per day, 2-5 years — 41% of everything it billed.
33Billing provider infoUT MEDICAL GROUP INC
MEMPHIS, TN 38119
MEMPHIS, TN 38119
33aNPI1780676650assigned 08/17/2005
33bProvider typeHealth Psychologist
28Total paid$53.16M
24GClaims1,074,727
24DCodes billed228
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 159,997 | $6.53M | |
| 2019 | 162,079 | $7.21M | |
| 2020 | 140,207 | $5.91M | |
| 2021 | 136,054 | $8.04M | |
| 2022 | 155,046 | $9.48M | |
| 2023 | 194,093 | $9.87M | |
| 2024incomplete | 127,251 | $6.11M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99472 | Subsequent inpatient pediatric critical care, per day, 2-5 years | 41% | 65,906 | 12,979 | $21.73M |
| 99469 | Subsequent inpatient neonatal critical care, per day, 28 days or younger | 9.0% | 15,525 | 4,178 | $4.80M |
| 99479 | Subsequent intensive care, per day, very low birth weight infant | 8.6% | 44,297 | 12,718 | $4.58M |
| 99480 | Subsequent intensive care, per day, low birth weight infant | 8.4% | 47,223 | 12,804 | $4.45M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.0% | 65,491 | 45,853 | $3.17M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.0% | 70,945 | 52,258 | $2.64M |
| 99238 | Hospital discharge day management, 30 minutes or less | 1.8% | 17,078 | 13,819 | $966K |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | 1.8% | 17,654 | 12,443 | $954K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 1.6% | 43,390 | 13,246 | $863K |
| 99460 | 1.6% | 12,281 | 9,940 | $829K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.4% | 13,774 | 10,661 | $753K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 8,871 | 6,157 | $460K |
216 more codes
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 4,775 | $449K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 9,157 | $409K |
| 90961 | <1% | 7,285 | $357K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 9,350 | $354K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 4,849 | $327K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 12,046 | $289K |
| 36902 | <1% | 3,616 | $289K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 6,667 | $237K |
| 99477 | <1% | 791 | $236K | |
| 99462 | <1% | 5,661 | $169K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 2,638 | $167K |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 8,068 | $158K |
| 31231 | <1% | 1,483 | $150K | |
| H0016 | Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting) | <1% | 844 | $148K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 3,529 | $144K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,257 | $134K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 1,457 | $112K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 5,562 | $103K |
| 11750 | <1% | 831 | $102K | |
| 99205 | Prolong outpt/office vis | <1% | 1,062 | $101K |
| 11721 | <1% | 9,602 | $101K | |
| 73620 | <1% | 9,196 | $99K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 6,450 | $91K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 2,433 | $86K |
| 99478 | <1% | 808 | $86K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,300 | $83K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,044 | $81K |
| 92134 | <1% | 5,644 | $76K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 2,909 | $61K |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 1,345 | $53K |
| H2010 | Comprehensive medication services, per 15 minutes | <1% | 959 | $51K |
| 11056 | <1% | 4,041 | $51K | |
| 81025 | <1% | 10,695 | $50K | |
| 99493 | <1% | 646 | $47K | |
| 88307 | <1% | 755 | $46K | |
| 59514 | <1% | 429 | $46K | |
| 99468 | <1% | 62 | $44K | |
| 96127 | <1% | 12,689 | $43K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 1,780 | $42K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 519 | $42K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,302 | $42K |
| 37248 | <1% | 235 | $40K | |
| 36512 | <1% | 1,053 | $39K | |
| 36907 | <1% | 524 | $37K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 2,123 | $37K |
| 80305 | <1% | 7,273 | $32K | |
| 59025 | Fetal non-stress test | <1% | 1,596 | $32K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 148 | $31K |
| 99223 | Prolong inpt eval add15 m | <1% | 758 | $31K |
| 1159F | <1% | 114,591 | $30K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 1,925 | $29K |
| 99490 | Ccm add 20min | <1% | 1,942 | $29K |
| 1160F | <1% | 51,140 | $28K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,712 | $28K |
| 36581 | <1% | 449 | $27K | |
| 90686 | <1% | 3,004 | $27K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 18,955 | $26K |
| 36215 | <1% | 662 | $26K | |
| 99494 | <1% | 609 | $25K | |
| 92083 | <1% | 1,230 | $24K | |
| 99492 | <1% | 223 | $22K | |
| 95720 | <1% | 413 | $22K | |
| 11100 | <1% | 527 | $22K | |
| 88342 | <1% | 803 | $22K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 1,237 | $21K |
| 3008F | <1% | 79,243 | $19K | |
| 36901 | <1% | 312 | $19K | |
| 76937 | <1% | 7,107 | $18K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 194 | $15K |
| 11305 | <1% | 412 | $14K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,491 | $14K |
| 99152 | <1% | 3,021 | $12K | |
| 17110 | <1% | 186 | $12K | |
| 90962 | <1% | 327 | $11K | |
| 11755 | <1% | 228 | $11K | |
| 92133 | <1% | 653 | $11K | |
| L3000 | Foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell, each | <1% | 39 | $10K |
| 88304 | <1% | 1,050 | $9K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 457 | $9K |
| 95718 | <1% | 167 | $9K | |
| 77001 | <1% | 1,140 | $9K | |
| 99463 | <1% | 116 | $9K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 670 | $9K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 273 | $9K |
| 92136 | <1% | 389 | $9K | |
| 99464 | <1% | 121 | $9K | |
| 99484 | <1% | 277 | $8K | |
| 97597 | <1% | 624 | $8K | |
| 37252 | <1% | 83 | $8K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 141 | $8K |
| 90651 | <1% | 133 | $8K | |
| 95812 | <1% | 409 | $8K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 106 | $8K |
| L1902 | Ankle orthosis, ankle gauntlet or similar, with or without joints, prefabricated, off-the-shelf | <1% | 271 | $7K |
| V2784 | Lens, polycarbonate or equal, any index, per lens | <1% | 262 | $7K |
| 92551 | <1% | 709 | $6K | |
| 95819 | <1% | 276 | $6K | |
| 36595 | <1% | 253 | $6K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,428 | $6K |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 375 | $5K |
| 95816 | <1% | 287 | $5K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 74 | $5K |
| 87210 | <1% | 1,242 | $5K | |
| 43775 | <1% | 31 | $5K | |
| 80306 | <1% | 597 | $5K | |
| 75901 | <1% | 280 | $5K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 164 | $5K |
| 36589 | <1% | 102 | $5K | |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | <1% | 262 | $4K |
| 80053 | Comprehensive metabolic panel | <1% | 1,502 | $4K |
| 11102 | <1% | 82 | $4K | |
| 92285 | <1% | 288 | $4K | |
| V2020 | Frames, purchases | <1% | 293 | $4K |
| 99217 | <1% | 66 | $4K | |
| 37253 | <1% | 81 | $4K | |
| 64455 | <1% | 235 | $4K | |
| 88341 | <1% | 103 | $4K | |
| 99219 | <1% | 35 | $4K | |
| 3079F | <1% | 13,076 | $3K | |
| 99234 | <1% | 29 | $3K | |
| 77014 | <1% | 396 | $3K | |
| 3074F | <1% | 30,536 | $3K | |
| 82962 | <1% | 2,277 | $3K | |
| J0178 | Injection, aflibercept, 1 mg | <1% | 27 | $3K |
| 92015 | Determination of refractive state | <1% | 583 | $3K |
| 90670 | <1% | 1,716 | $3K | |
| 93886 | <1% | 296 | $3K | |
| 99173 | <1% | 765 | $2K | |
| 3078F | <1% | 25,671 | $2K | |
| 36905 | <1% | 15 | $2K | |
| 99201 | <1% | 85 | $2K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 72 | $2K |
| 0011A | <1% | 94 | $2K | |
| 88313 | <1% | 184 | $2K | |
| 99254 | <1% | 14 | $2K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 69 | $2K |
| 99442 | <1% | 111 | $2K | |
| 99283 | Emergency room visit (moderate) | <1% | 40 | $2K |
| 3077F | <1% | 4,551 | $2K | |
| 3075F | <1% | 5,441 | $2K | |
| 92557 | <1% | 80 | $2K | |
| 92002 | <1% | 45 | $2K | |
| 90715 | <1% | 60 | $2K | |
| 31575 | <1% | 27 | $1K | |
| 92567 | <1% | 171 | $1K | |
| 90966 | <1% | 99 | $1K | |
| 11055 | <1% | 155 | $1K | |
| 90656 | <1% | 192 | $1K | |
| 99401 | <1% | 147 | $1K | |
| 3080F | <1% | 2,344 | $1K | |
| 90837 | Psychotherapy session, about an hour | <1% | 32 | $1K |
| 92020 | <1% | 151 | $1K | |
| 11057 | <1% | 46 | $983.87 | |
| 99221 | <1% | 51 | $914.96 | |
| 85045 | <1% | 798 | $884.92 | |
| 99443 | <1% | 82 | $852.21 | |
| 92025 | <1% | 97 | $845.29 | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 17 | $836.86 |
| 99153 | Mod sedat endo service >5yrs | <1% | 332 | $777.66 |
| 11104 | <1% | 13 | $773.08 | |
| 96900 | <1% | 48 | $761.10 | |
| 90836 | <1% | 36 | $747.53 | |
| 88312 | <1% | 29 | $733.62 | |
| 76512 | <1% | 58 | $714.01 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 288 | $668.94 |
| 92250 | <1% | 72 | $609.04 | |
| 99487 | Ccm add 20min | <1% | 12 | $599.03 |
| 90682 | <1% | 33 | $587.70 | |
| 99439 | <1% | 29 | $561.58 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 275 | $542.87 |
| 99459 | <1% | 39 | $532.81 | |
| 11900 | <1% | 19 | $460.39 | |
| 75710 | <1% | 65 | $418.71 | |
| 77336 | <1% | 75 | $364.36 | |
| 76513 | <1% | 19 | $363.20 | |
| 99441 | <1% | 40 | $353.57 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 26 | $349.24 |
| 76514 | <1% | 92 | $338.89 | |
| 83986 | <1% | 263 | $336.41 | |
| 81002 | <1% | 157 | $299.58 | |
| 90970 | <1% | 182 | $227.24 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,380 | $221.66 |
| 90785 | <1% | 41 | $198.14 | |
| 96161 | <1% | 54 | $185.38 | |
| 90461 | <1% | 4,585 | $181.50 | |
| 85018 | <1% | 124 | $120.92 | |
| 90723 | <1% | 223 | $104.67 | |
| 11101 | <1% | 21 | $82.60 | |
| 99421 | <1% | 26 | $71.92 | |
| 81003 | <1% | 43 | $57.48 | |
| 90662 | <1% | 21 | $53.34 | |
| 0500F | <1% | 50 | $40.19 | |
| 99024 | <1% | 739 | $20.78 | |
| 0502F | <1% | 12,243 | $10.00 | |
| G0008 | Administration of influenza virus vaccine | <1% | 50 | $4.64 |
| 1026F | <1% | 17,159 | $1.11 | |
| 90680 | <1% | 237 | $0.05 | |
| 0503F | <1% | 16 | $0.05 | |
| 1126F | <1% | 25,187 | $0.04 | |
| 90633 | 0% | 164 | $0.00 | |
| 90648 | 0% | 150 | $0.00 | |
| M1016 | Female patients unable to bear children | 0% | 748 | $0.00 |
| 3046F | 0% | 83 | $0.00 | |
| G9500 | Radiation exposure indices documented in final report for procedure using fluoroscopy | 0% | 128 | $0.00 |
| 90713 | 0% | 46 | $0.00 | |
| 90700 | 0% | 100 | $0.00 | |
| 3725F | 0% | 37 | $0.00 | |
| 1125F | 0% | 3,187 | $0.00 | |
| 3044F | 0% | 818 | $0.00 | |
| 90698 | 0% | 88 | $0.00 | |
| 3048F | 0% | 50 | $0.00 | |
| 99000 | 0% | 148 | $0.00 | |
| 99002 | 0% | 39 | $0.00 | |
| G0410 | Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes | 0% | 80 | $0.00 |
| 90697 | 0% | 29 | $0.00 | |
| 90647 | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLOVE, COURTNEY (CHIEF ADMINISTRATIVE OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Memphis Surgery Center LTD, LP | Memphis, TN | $43K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.